Searched for
GENERIC LEVOTHYROXINE
Over 158 applications for generic products pending with USFDA for approval: LupinSharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business stabilised last ...20 Jul, 2020, 03.33 PM IST- Add Lupin, target price Rs 890: CentrumThe brokerage expects the India business to report healthy double digit growth for the company and emerge as a key growth driver.03 Jun, 2020, 08.27 AM IST
- Lupin posts net loss of Rs 123 crore in September quarterTotal revenue from operations stood at Rs 4,359.65 crore for the second quarter.06 Nov, 2019, 05.39 PM IST
- Lupin launches Levothyroxine Sodium tablets in USThe tablets are indicated as replacement or supplemental therapy for hypothyroidism.22 Mar, 2019, 03.37 PM IST
- Buy Lupin, target Rs 985: HDFC SecuritiesBuy Lupin at a price target of Rs 985.11 Feb, 2019, 12.33 PM IST
- Buy Lupin, target Rs 1,030: HDFC SecuritiesBuy Lupin at a price target of Rs 1030.02 Nov, 2018, 08.44 AM IST
- Lupin still on track to meet $800-million FY19 sales target: Ramesh SwaminathanThings not as bad as they were in the past and should be looking better, says Lupin CFO.01 Nov, 2018, 04.04 PM IST
- For every rupee depreciation, we expect to add Rs 40 cr to bottom line: Ramesh Swaminathan, Lupin“Between 25% and 30% of our total exposures are hedged.”24 Sep, 2018, 03.35 PM IST
- We expect domestic business to grow at 15%: S Ramesh, LupinI expect the price erosion to continue in America in the first two quarters at least for the current year before it stabilises around 8-10%.09 Apr, 2018, 03.02 PM IST
- For Lupin, uncertainties of FY18 would continue in FY19: Ramesh Swaminathan“Biosimilars, complex generics and speciality would be key elements of Lupin strategy going forward”04 Jan, 2018, 05.34 PM IST
Load More
